Cited by 2,120Alzheimer's disease research and treatmentsTrace Elements in HealthDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index.

Copper, iron and zinc in Alzheimer's disease senile plaques

Lovell, M.A, Robertson, J.D, Teesdale, W.J, Campbell, J.L, Markesbery, W.R·1998·Journal of the Neurological Sciences

DOI 10.1016/s0022-510x(98)00092-6

Open this paper in CoChat — free account

Abstract

Concentrations of copper (Cu), iron (Fe) and zinc (Zn) were measured in the rims and cores of senile plaques (SP) and in the neuropil of the amygdala of nine Alzheimer's disease (AD) patients and in the neuropil of the amygdala of five neurologically normal control subjects using micro particle-induced X-ray emission (micro-PIXE). Comparison of SP rim and core values revealed no significant differences between levels of Cu, Fe or Zn. Zinc and Fe in SP rims and cores were significantly elevated in AD compared with AD neuropil (P<0.05). Copper was significantly elevated (P<0.05) in the rim of SP compared with AD neuropil. Comparison of AD and control neuropil revealed a significant (P<0.05) elevation of Zn in AD subjects. The elevation of these elements in SP in AD is of interest in light of the observation that Cu, Fe and particularly Zn, can accelerate aggregation of amyloid beta peptide.

Integrity signals

Registry

Crossref · 10.1016/s0022-510x(98)00092-6

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Self-citation
Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported
Evans, D. A. (1989) · JAMA · doi:10.1001/jama.262.18.2551 · Cited by 1,627
Rapid induction of Alzheimer A beta amyloid formation by zinc
Bush, A., Pettingell, W., Multhaup, G., d Paradis, M., Vonsattel, J., Gusella, J., Beyreuther, K., Masters, C., & Tanzi, R. (1994) · Science · doi:10.1126/science.8073293 · Cited by 1,522
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Self-citation
Release of endogenous Zn2+ from brain tissue during activity
Assaf, S. Y., & Chung, S. (1984) · Nature · doi:10.1038/308734a0 · Cited by 1,113
A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.
Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086

Show all 72 references

Research works printed but not linked: 3

Ben-Shachar, 1987, Dopamine D2 receptor modulation by brain non-haem iron, Br J Pharmacol, 90, 2P
Hess, 1974, Chronische Bleivergiftung. Praxis, 63, 177
Markesbery WR, Ehmann WD. Brain trace elements in Alzheimer disease. In: Terry RD, Katzman R, Bick KL, editors. Alzheimer disease. New York: Raven Press, 1994:353–67.

Sorted by citations

Items 601–700 of 1,007

Metal-deficient aggregates and diminished copper found in cells expressing SOD1 mutations that cause ALS
Bourassa, M. W., Brown, H. H., Borchelt, D., Vogt, S., & Miller, L. M. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00110 · Cited by 74
Investigations of the Molecular Mechanism of Metal-Induced Aβ (1−40) Amyloidogenesis
Lim, K. H., Kim, Y. K., & Chang, Y. (2007) · Biochemistry · doi:10.1021/bi701112z · Cited by 71
A rationally designed small molecule for identifying an in vivo link between metal–amyloid-β complexes and the pathogenesis of Alzheimer's disease
Beck, M. W., Oh, S. B., Kerr, R. A., Lee, H. J., Kim, S., Kim, S., Jang, M., Ruotolo, B. T., Lee, J., & Lim, M. H. (2015) · Chemical Science · doi:10.1039/c4sc03239j · Cited by 71
Applications and bioefficacy of the functional food supplement fermented papaya preparation
Aruoma, O. I., Hayashi, Y., Marotta, F., Mantello, P., Rachmilewitz, E. A., & Montagnier, L. (2010) · Toxicology · doi:10.1016/j.tox.2010.09.006 · Cited by 71
Metalloproteomics: principles, challenges and applications to neurodegeneration
Lothian, A., Hare, D. J., Grimm, R., Ryan, T. M., Masters, C. L., & Roberts, B. R. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00035 · Cited by 71
Brain biometals and Alzheimer's disease – boon or bane?
Prakash, A. K., Dhaliwal, G. K., Kumar, P., & Majeed, A. B. A. (2016) · International Journal of Neuroscience · doi:10.3109/00207454.2016.1174118 · Cited by 71
Metal-involved theranostics: An emerging strategy for fighting Alzheimer’s disease
Wang, X., Wang, X., & Guo, Z. (2018) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.03.010 · Cited by 72
Serum Zinc Levels and Alzheimer's Disease
Rulon, L. L., Robertson, J. D., Lovell, M. A., Deibel, M. A., Ehmann, W. D., & Markesbery, W. R. (2000) · Biological Trace Element Research · doi:10.1385/bter:75:1-3:79 · Cited by 71
Self-citation
Hydroxyquinoline based binders: Promising ligands for chelatotherapy?
Budimir, A., Humbert, N., Elhabiri, M., Nierengarten, I., Biruš, M., & Albrecht‐Gary, A. (2010) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2010.08.014 · Cited by 71
Metal Loading Capacity of Aβ N-Terminus: a Combined Potentiometric and Spectroscopic Study of Zinc(II) Complexes with Aβ(1−16), Its Short or Mutated Peptide Fragments and Its Polyethylene Glycol−ylated Analogue
Damante, C. A., Ösz, K., Nagy, Z., Pappalardo, G., Grasso, G., Impellizzeri, G., Rizzarelli, E., & Sóvágó, I. (2009) · Inorganic Chemistry · doi:10.1021/ic9012334 · Cited by 70
Baicalin prevents the production of hydrogen peroxide and oxidative stress induced by Aβ aggregation in SH-SY5Y cells
Yin, F., Liu, J., Ji, X., Wang, Y., Zidichouski, J. A., & Zhang, J. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.01.055 · Cited by 70
Comparative effects of metal chelating agents on the neuronal cytotoxicity induced by copper (Cu+2), iron (Fe+3) and zinc in the hippocampus
Armstrong, C., Leong, W., & Lees, G. J. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03195-4 · Cited by 70
Zinc and Health: Current Status and Future Directions
Hambidge, M. (2000) · Cited by 70
Neurotoxicity of Zinc
Morris, D. R., & Levenson, C. W. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-60189-2_15 · Cited by 74
Nicotine attenuates the β‐amyloid neurotoxicity through regulating metal homeostasis
Zhang, J., Liu, Q., Chen, Q., Liu, N.-Q., Li, F., Lu, Z., Qin, C., Zhu, H., Huang, Y., He, W., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5214fje · Cited by 70
The Positive Side of the Alzheimer’s Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1
Ciccone, L., Shi, C., di Lorenzo, D., Van Baelen, A.-C., & Tonali, N. (2020) · Molecules · doi:10.3390/molecules25102439 · Cited by 69
Protective Effects of Flavonoids against Alzheimer’s Disease: Pathological Hypothesis, Potential Targets, and Structure–Activity Relationship
Li, J., Sun, M., Cui, X., & Li, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710020 · Cited by 71
Altered expression and distribution of zinc transporters in APP/PS1 transgenic mouse brain
Zhang, L., Wang, X., Zheng, Z., Ren, H., Stoltenberg, M., Danscher, G., Huang, L., Rong, M., & Wang, Z. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.02.018 · Cited by 69
Decreased Copper in Alzheimer’s Disease Brain Is Predominantly in the Soluble Extractable Fraction
Rembach, A., Hare, D. J., Lind, M., Fowler, C. J., Cherny, R. A., McLean, C., Bush, A. I., Masters, C. L., & Roberts, B. R. (2013) · International Journal of Alzheimer s Disease · doi:10.1155/2013/623241 · Cited by 69
Neurodegenerative Disorders and Nanoformulated Drug Development
Nowacek, A. S., Kosloski, L. M., & Gendelman, H. E. (2009) · Nanomedicine · doi:10.2217/nnm.09.37 · Cited by 69
Evidence of Redox-Active Iron Formation Following Aggregation of Ferrihydrite and the Alzheimer’s Disease Peptide β-Amyloid
Everett, J. L., Céspedes, E., Shelford, L. R., Exley, C., Collingwood, J. F., Dobson, J., van der Laan, G., Jenkins, C., Arenholz, E., & Telling, N. D. (2014) · Inorganic Chemistry · doi:10.1021/ic402406g · Cited by 68
Fragment length influences affinity for Cu2+ and Ni2+ binding to His96 or His111 of the prion protein and spectroscopic evidence for a multiple histidine binding only at low pH
Klewpatinond, M., & Viles, J. H. (2007) · Biochemical Journal · doi:10.1042/bj20061893 · Cited by 68
N-Aryl-substituted 3-(β-D-glucopyranosyloxy)-2-methyl-4(1H)-pyridinones as agents for Alzheimer's therapy
Scott, L. E., Telpoukhovskaia, M., Rodríguez-Rodríguez, C., Merkel, M., Bowen, M. L., Page, B. D. G., Green, D. E., Storr, T., Thomas, F., Allen, D. D., et al. (2011) · Chem. Sci. · doi:10.1039/c0sc00544d · Cited by 68
PET Imaging of Copper Trafficking in a Mouse Model of Alzheimer Disease
Torres, J. B., Andreozzi, E. M., Dunn, J., Siddique, M., Szanda, I., Howlett, D. R., Sunassee, K., & Blower, P. J. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.162370 · Cited by 67
Laser ablation-inductively coupled plasma-mass spectrometry imaging of white and gray matter iron distribution in Alzheimer's disease frontal cortex
Hare, D. J., Raven, E. P., Roberts, B. R., Bogeski, M., Portbury, S. D., McLean, C., Masters, C. L., Connor, J. R., Bush, A. I., Crouch, P. J., et al. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.05.057 · Cited by 70
Amyloid-β Metal Interaction and Metal Chelation
Cuajungco, M. P., Frederickson, C. J., & Bush, A. I. (2006) · Springer eBooks · doi:10.1007/0-387-23226-5_12 · Cited by 68
Copper deficiency elicits glial and neuronal response typical of neurodegenerative disorders
Zucconi, G. G., Cipriani, S., Scattoni, R., Balgkouranidou, I., Hawkins, D. P., & Ragnarsdottir, K. V. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00793.x · Cited by 67
Effect of metal ions on Alzheimer's disease
Liu, F., Zhang, Z., Zhang, L., Meng, R., Gao, J., Jin, M., Li, M., & Wang, X. (2022) · Brain and Behavior · doi:10.1002/brb3.2527 · Cited by 67
ZnT3 mRNA levels are reduced in Alzheimer's disease post-mortem brain
Beyer, N., Coulson, D. T. R., Heggarty, S., Ravid, R., Irvine, G. B., Hellemans, J., & Johnston, J. A. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-53 · Cited by 70
Amyloid β-interacting partners in Alzheimer's disease: From accomplices to possible therapeutic targets
Han, S.-H., Park, J.-C., & Mook-Jung, I. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.004 · Cited by 67
Advances in Multi-Functional Ligands and the Need for Metal-Related Pharmacology for the Management of Alzheimer Disease
Sharma, A., Pachauri, V., & Flora, S. J. S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01247 · Cited by 67
Oxidative Stress and Neuronal Adaptation in Alzheimer Disease: The Role of SAPK Pathways
Zhu, X., Raina, A. K., Lee, H., Chao, M. P., Nunomura, A., Tabaton, M., Petersen, R. B., Perry, G. L., & Smith, M. A. (2003) · Antioxidants and Redox Signaling · doi:10.1089/152308603770310220 · Cited by 67
Neurotoxicity from glutathione depletion is dependent on extracellular trace copper
White, A. R., & Cappai, R. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10537 · Cited by 66
A Multimodal Spectroscopic Imaging Method To Characterize the Metal and Macromolecular Content of Proteinaceous Aggregates (“Amyloid Plaques”)
Summers, K. L., Fimognari, N., Hollings, A. L., Kiernan, M., Lam, V., Tidy, R. J., Paterson, D. J., Tobin, M. J., Takechi, R., George, G. N., et al. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00262 · Cited by 67
Trientine Reduces BACE1 Activity and Mitigates Amyloidosis via the AGE/RAGE/NF-κB Pathway in a Transgenic Mouse Model of Alzheimer's Disease
Wang, C.-Y., Xie, J.-W., Xu, Y., Wang, T., Cai, J.-H., Wang, X., Zhao, B.-L., An, L., & Wang, Z.-Y. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5158 · Cited by 66
Role of Metal Cations of Copper, Iron, and Aluminum and Multifunctional Ligands in Alzheimer’s Disease: Experimental and Computational Insights
Puentes-Díaz, N., Chaparro, D., Morales-Morales, D., Flores-Gaspar, A., & Alí-Torres, J. (2023) · ACS Omega · doi:10.1021/acsomega.2c06939 · Cited by 67
Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer’s Disease
Kim, N., & Lee, H. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147697 · Cited by 67
Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases
Riccardi, C., Napolitano, F., Montesarchio, D., Sampaolo, S., & Melone, M. A. B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111897 · Cited by 70
PET molecular imaging for pathophysiological visualization in Alzheimer’s disease
Wang, J., Jin, C., Zhou, J., Zhou, R., Tian, M., Lee, H. J., & Zhang, H. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05999-z · Cited by 71
Molecular Mechanisms Underlying Neuroinflammation Elicited by Occupational Injuries and Toxicants
Pathak, D., & Sriram, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032272 · Cited by 72
Copper-Triggered Aggregation of Ubiquitin
Arnesano, F., Scintilla, S., Calò, V., Bonfrate, E., Ingrosso, C., Losacco, M., Pellegrino, T., Rizzarelli, E., & Natile, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007052 · Cited by 68
Fermented papaya preparation attenuates β-amyloid precursor protein: β-amyloid–mediated copper neurotoxicity in β-amyloid precursor protein and β-amyloid precursor protein Swedish mutation overexpressing SH-SY5Y cells
Zhang, J., Mori, A., Chen, Q., & Zhao, B. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.023 · Cited by 66
Neurotherapeutic applications of nanomedicine for treating Alzheimer's disease
Wilson, B., & Geetha, K. M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.05.044 · Cited by 67
Impact of Cu(II) Binding on Structures and Dynamics of Aβ42 Monomer and Dimer: Molecular Dynamics Study
Huy, P. D. Q., Vuong, V., Penna, G. L., Faller, P., & Li, M. S. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00109 · Cited by 64
The Neuromelanin Paradox and Its Dual Role in Oxidative Stress and Neurodegeneration
Moreno-García, A., Kun, A., Calero, M., & Calero, O. (2021) · Antioxidants · doi:10.3390/antiox10010124 · Cited by 66
Copper Imbalance in Alzheimer’s Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology
Squitti, R., Faller, P., Hureau, C., Granzotto, A., White, A. R., & Kepp, K. P. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201556 · Cited by 67
Copper Metabolism and Cuproptosis: Molecular Mechanisms and Therapeutic Perspectives in Neurodegenerative Diseases
Ban, X.-X., Wan, H., Wan, X.-X., Tan, Y.-T., Hu, X., Ban, H.-X., Chen, X., Huang, K. L., Zhāng, Q., & Xiong, K. (2024) · Current Medical Science · doi:10.1007/s11596-024-2832-z · Cited by 68
Modulation of mitochondrial membrane potential and reactive oxygen species production by copper in astrocytes
Gyulkhandanyan, A. V., Feeney, C. J., & Pennefather, P. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02029.x · Cited by 65
Cerebrovascular requirement for sealant, anti-coagulant and remodeling molecules that allow for the maintenance of vascular integrity and blood supply
Atwood, C., Bowen, R. L., Smith, M. A., & Perry, G. L. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00206-6 · Cited by 64
Influence of Multiple Metal Ions on β-Amyloid Aggregation and Dissociation on a Solid Surface
Ryu, J., Girigoswami, K., Ha, C., Ku, S. H., & Park, C. B. (2008) · Biochemistry · doi:10.1021/bi800012e · Cited by 66
Diagnostic imaging of Alzheimer's disease with copper and technetium complexes
Hickey, J. L., & Donnelly, P. S. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.035 · Cited by 65
Neuroinflammation and Copper in Alzheimer’s Disease
Choo, X. Y., Alukaidey, L., White, A. R., & Grubman, A. (2013) · International Journal of Alzheimer s Disease · doi:10.1155/2013/145345 · Cited by 70
High-field Magnetic Resonance Imaging of Brain Iron in Alzheimer Disease
Schenck, J. F., Zimmerman, E. A., Li, Z., Adak, S., Saha, A., Tandon, R., Fish, K. M., Belden, C. J., Gillen, R. W., Barba, A., et al. (2006) · Topics in Magnetic Resonance Imaging · doi:10.1097/01.rmr.0000245455.59912.40 · Cited by 65
Characterization of New Specific Copper Chelators as Potential Drugs for the Treatment of Alzheimer’s Disease
Nguyen, M., Robert, A., Sournia‐Saquet, A., Vendier, L., & Meunier, B. (2014) · Chemistry - A European Journal · doi:10.1002/chem.201402143 · Cited by 67
Metal binding to the amyloid-β peptides in the presence of biomembranes: potential mechanisms of cell toxicity
Wärmländer, S. K. T. S., Österlund, N., Wallin, C., Wu, J., Luo, J., Tiiman, A., Jarvet, J., & Gräslund, A. (2019) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-019-01723-9 · Cited by 64
Copper(II) complexation by human and mouse fragments (11–16) of β-amyloid peptide
Kowalik‐Jankowska, T., Ruta-Dolejsz, M., Wiśniewska, K., Łankiewicz, L., & Kozłowski, H. (2000) · Journal of the Chemical Society Dalton Transactions · doi:10.1039/b006125p · Cited by 65
Aβ[25–35] Peptide and Iron Promote Apoptosis in Lymphocytes by an Oxidative Stress Mechanism: Involvement of H2O2, Caspase-3, NF-κB, p53 and c-Jun
Velez-Pardo, C., Garcia Ospina, G., & Jimenez del Rio, M. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00081-5 · Cited by 63
Positive Feedback Loops in Alzheimer’s Disease: The Alzheimer’s Feedback Hypothesis
Doig, A. J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180583 · Cited by 67
The Bidirectional Relationship Between Sleep and Inflammation Links Traumatic Brain Injury and Alzheimer’s Disease
Green, T. R. F., Ortiz, J. B., Wonnacott, S., Williams, R. J., & Rowe, R. K. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00894 · Cited by 68
Selenoprotein P and selenoprotein M block Zn2+-mediated Aβ42 aggregation and toxicity
Du, X., Li, H., Wang, Z., Qiu, S., Liu, Q., & Ni, J. (2013) · Metallomics · doi:10.1039/c3mt20282h · Cited by 67
Paradoxical Condensation of Copper with Elevated β-Amyloid in Lipid Rafts under Cellular Copper Deficiency Conditions
Hung, Y. H., Robb, E. L., Volitakis, I., Ho, M., Evin, G. M., Li, Q.-X., Culvenor, J. G., Masters, C. L., Cherny, R. A., & Bush, A. I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.019521 · Cited by 64
Coaccumulation of Calcium and β-Amyloid in the Thalamus after Transient Middle Cerebral Artery Occlusion in Rats
Mäkinen, S., van Groen, T., Clarke, J., Thornell, A., Corbett, D., Hiltunen, M. O., Soininen, H. S., & Jolkkonen, J. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600529 · Cited by 64
The Elevated Copper Binding Strength of Amyloid-β Aggregates Allows the Sequestration of Copper from Albumin: A Pathway to Accumulation of Copper in Senile Plaques
Jiang, D., Zhang, L., Grant, G. P. G., Dudzik, C. G., Chen, S., Patel, S., Hao, Y., Millhauser, G. L., & Zhou, F. (2012) · Biochemistry · doi:10.1021/bi301053h · Cited by 64
Iron chelation as a potential therapy for neurodegenerative disease
Hider, R. C., Ma, Y., Molina‐Holgado, F., Gaeta, A., & Roy, S. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361304 · Cited by 64
Novel 5′ Untranslated Region Directed Blockers of Iron-Regulatory Protein-1 Dependent Amyloid Precursor Protein Translation: Implications for Down Syndrome and Alzheimer's Disease
Bandyopadhyay, S., Cahill, C. M., Balleidier, A., Huang, C., Lahiri, D. K., Huang, X., & Rogers, J. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065978 · Cited by 64
Bimodal modulation of tau protein phosphorylation and conformation by extracellular Zn2+ in human-tau transfected cells
Boom, A., Authelet, M., Dedecker, R., Frédérick, C., Heurck, R. V., Daubie, V., Leroy, K., Pochet, R., & Brion, J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.011 · Cited by 64
Cu2+ accentuates distinct misfolding of Aβ(1–40) and Aβ(1–42) peptides, and potentiates membrane disruption
Matheou, C. J., Younan, N. D., & Viles, J. H. (2014) · Biochemical Journal · doi:10.1042/bj20141168 · Cited by 64
Characterization of superparamagnetic iron oxide nanoparticle-induced apoptosis in PC12 cells and mouse hippocampus and striatum
Liu, Y., Li, J., Xu, K., Gu, J., Huang, L. H., Zhang, L., Liu, N., Kong, J., Xing, M. M. Q., Zhang, L., et al. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.04.033 · Cited by 65
Copper Redox Cycling Inhibits Aβ Fibre Formation and Promotes Fibre Fragmentation, while Generating a Dityrosine Aβ Dimer
Gu, M., Bode, D. C., & Viles, J. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-33935-5 · Cited by 66
1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer’s disease
Wichur, T., Więckowska, A., Więckowski, K., Godyń, J., Jończyk, J., Valdivieso, Á. D. R., Panek, D., Pasieka, A., Sabaté, R., Knez, D., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111916 · Cited by 63
Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain 1 1Edited by A. Fersht
Davis, D. P., Gallo, G., Vogen, S. M., Dul, J. L., Sciarretta, K. L., Kumar, A. R., Wilton, R., Stevens, F. J., & Argon, Y. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5092 · Cited by 63
Copper ions influence the toxicity of β-amyloid(1–42) in a concentration-dependent manner in a Caenorhabditis elegans model of Alzheimer’s disease
Luo, Y., Zhang, J., Liu, N., Luo, Y., & Zhao, B. (2011) · Science China Life Sciences · doi:10.1007/s11427-011-4180-z · Cited by 63
Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease
Rahmadi, A., Steiner, N., & Münch, G. W. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.079 · Cited by 63
Metals in Alzheimer’s Disease
Leko, M. B., Horvat, L. L., Španić, E., Zubčić, K., Hof, P. R., & Šimić, G. (2023) · Biomedicines · doi:10.3390/biomedicines11041161 · Cited by 64
Modest Amyloid Deposition is Associated with Iron Dysregulation, Microglial Activation, and Oxidative Stress
Gallagher, J. J., Finnegan, M. E., Grehan, B., Dobson, J., Collingwood, J. F., & Lynch, M. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110614 · Cited by 64
The Amyloid Paradox: Amyloid‐β‐Metal Complexes can be Neurotoxic and Neuroprotective
Bishop, G. M., & Robinson, S. R. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00089.x · Cited by 65
Expanding the chemistry of fluorescent protein biosensors through genetic incorporation of unnatural amino acids
Niu, W., & Guo, J. (2013) · Molecular BioSystems · doi:10.1039/c3mb70204a · Cited by 63
Reactivity of Metal-Free and Metal-Associated Amyloid-β with Glycosylated Polyphenols and Their Esterified Derivatives
Korshavn, K. J., Jang, M., Kwak, Y. J., Kochi, A., Vertuani, S., Bhunia, A., Manfredini, S., Ramamoorthy, A., & Lim, M. H. (2015) · Scientific Reports · doi:10.1038/srep17842 · Cited by 64
Truncated Amyloid-β(11–40/42) from Alzheimer Disease Binds Cu2+ with a Femtomolar Affinity and Influences Fiber Assembly
Barritt, J. D., & Viles, J. H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.684084 · Cited by 62
Transition Metal Ion Interactions with Disordered Amyloid-β Peptides in the Pathogenesis of Alzheimer’s Disease: Insights from Computational Chemistry Studies
Strodel, B., & Coskuner‐Weber, O. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00983 · Cited by 63
Mechanisms of Modulation of Ferroptosis and Its Role in Central Nervous System Diseases
Tan, Q., Fang, Y., & Gu, Q. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.657033 · Cited by 64
Melatonin prevents free radical formation due to the interaction between β‐amyloid peptides and metal ions [Al(III), Zn(II), Cu(II), Mn(II), Fe(II)]
Zatta, P. F., Tognon, G., & Carampin, P. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.00058.x · Cited by 64
Strategies, Development, and Pitfalls of Therapeutic Options for Alzheimer's Disease
Haas, C. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110986 · Cited by 61
Differential modulation of Alzheimer's disease amyloid β-peptide accumulation by diverse classes of metal ligands
Caragounis, A., Du, T., Filiz, G., Laughton, K. M., Volitakis, I., Sharples, R. A., Cherny, R. A., Masters, C. L., Drew, S. C., Hill, A. F., et al. (2007) · Biochemical Journal · doi:10.1042/bj20070579 · Cited by 63
The Jackson toxic milk mouse as a model for copper loading
Coronado, V. A., Nanji, M. S., & Cox, D. W. (2001) · Mammalian Genome · doi:10.1007/s00335-001-3021-y · Cited by 62
Ceruloplasmin fragmentation is implicated in 'free' copper deregulation of Alzheimer disease
Squitti, R., Quattrocchi, C. C., Salustri, C., & Rossini, P. M. (2008) · Prion · doi:10.4161/pri.2.1.6297 · Cited by 62
Redox Imbalance and Viral Infections in Neurodegenerative Diseases
Limongi, D., & Baldelli, S. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/6547248 · Cited by 66
Paramagnetic Metal Ions in Pulsed ESR Distance Distribution Measurements
Ji, M., Ruthstein, S., & Saxena, S. (2013) · Accounts of Chemical Research · doi:10.1021/ar400245z · Cited by 65
The Relationship Between Copper, Iron, and Selenium Levels and Alzheimer Disease
Vaz, F. N. C., Fermino, B. L., Haskel, M. V. L., Wouk, J., Freitas, G. B. L. D., Fabbri, R., Montagna, E., da Rocha, J. B. T., & Bonini, J. S. (2017) · Biological Trace Element Research · doi:10.1007/s12011-017-1042-y · Cited by 62
Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: Reversal by cannabidiol
da Silva, V. K., de Freitas, B. S., Dornelles, V. C., Kist, L. W., Bogo, M. R., Silva, M. C., STRECK, E. L., Hallak, J. E. C., Zuardi, A. W., Crippa, J. A. S., et al. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.01.014 · Cited by 65
ERK activation and nuclear translocation in amyloid‐β peptide‐ and iron‐stressed neuronal cell cultures
Kuperstein, F., & Yavin, E. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02056.x · Cited by 62
Heme Oxygenase-1 (HSP-32) and Heme Oxygenase-2 Induction in Neurons and Glial Cells of Cerebral Regions and Its Relation to Iron Accumulation after Focal Cortical Photothrombosis
Bidmon, H. J., Emde, B., Oermann, E., Kubitz, R., Witte, O. W., & Zilles, K. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7456 · Cited by 62
Magnesium Modulates Amyloid-β Protein Precursor Trafficking and Processing
Yu, J. H., Sun, M., Chen, Z., Lu, J., Liu, Y., Zhou, L., Xu, X., Fan, D., & Chui, D. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091444 · Cited by 61
Effect of copper intake on CSF parameters in patients with mild Alzheimer’s disease: a pilot phase 2 clinical trial
Kessler, H., Pajonk, F.-G., Bach, D., Schneider-Axmann, T., Falkai, P., Herrmann, W., Multhaup, G., Wiltfang, J., Schäfer, S., Wirths, O., et al. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0136-2 · Cited by 61
Twenty years of metallo-neurobiology: where to now?
Bush, A. I., & Curtain, C. C. (2007) · European Biophysics Journal · doi:10.1007/s00249-007-0228-1 · Cited by 62
Effects of Zinc Binding on the Conformational Distribution of the Amyloid-β Peptide Based on Molecular Dynamics Simulations
Li, W., Zhang, J., Su, Y., Wang, J., Qin, M., & Wang, W. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp076213t · Cited by 61
The Aggregated State of Amyloid‐β Peptide In Vitro Depends on Cu2+ Ion Concentration
Jun, S., & Saxena, S. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200700318 · Cited by 61
Alzheimer’s Disease Biomarkers and Epigenetic Intermediates Following Exposure to Pb In Vitro
Bihaqi, S. W., & Zawia, N. H. (2012) · Current Alzheimer Research · doi:10.2174/156720512800617964 · Cited by 62
Tissue magnetic susceptibility mapping as a marker of tau pathology in Alzheimer's disease
O’Callaghan, J. M., Holmes, H. E., Powell, N. M., Wells, J. A., Ismail, O., Harrison, I. F., Siow, B. M., Johnson, R. A., Ahmed, Z., Fisher, A., et al. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.08.003 · Cited by 63
Probing copper/tau protein interactions electrochemically
Martic, S., Rains, M. K., & Kraatz, H.-B. (2013) · Analytical Biochemistry · doi:10.1016/j.ab.2013.07.015 · Cited by 60

Authors: Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R.
Affiliations: University of Kentucky (US)
University of Guelph (CA)
ORCID: Lovell, M.A
Robertson, J.D
Venue: Journal of the Neurological Sciences
Publisher: Elsevier BV
Published: 1998-06
Volume: 158
Issue: 1
Pages: 47-52
ISSN: 0022-510X (ISSN-L)
DOI: 10.1016/s0022-510x(98)00092-6
OpenAlex: W2083500052
Cited by: 2,120
References: 72
Citations by year: 2026: 38 · 2025: 52 · 2024: 69 · 2023: 82 · 2022: 100 · 2021: 92 · 2020: 95 · 2019: 103 · 2018: 80 · 2017: 94 · 2016: 87 · 2015: 82 · 2014: 89 · 2013: 96 · 2012: 116
FWCI: 18.64
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of the Neurological Sciences (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Aging (2-PO1-AG05119, P01AG005119, 5-P50 AG0514)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: Alzheimer's disease, amyloid plaques, copper, iron, zinc, trace elements, amygdala, amyloid-beta aggregation, neuropil
MeSH terms: Alzheimer Disease, Amygdala, Copper, Humans, Iron, Spectrometry, X-Ray Emission, Zinc, Neuropil, Biotinylation, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Copper, iron and zinc in Alzheimer's disease senile plaques

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks